Analysis of human clinical samples further reveals that the proportion of M1 Macrophages (CD86+, TNF-α+) is increased, whereas M2 Macrophages (CD206+) are reduced in MASLD patients (62). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.